Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment.

Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment.

Bibliographic Details
Main Authors:	Weinshenker, BG, Bass, B, Ebers, G, Rice, G
Format:	Journal article
Language:	English
Published:	1989

Similar Items

A PRELIMINARY CLINICAL-TRIAL OF ORTHOCLONE OKT-STAR-3 TREATMENT IN CHRONICALLY PROGRESSIVE MULTIPLE-SCLEROSIS
by: Weinshenker, B, et al.
Published: (1988)

An open trial of OKT3 in patients with multiple sclerosis.
by: Weinshenker, BG, et al.
Published: (1991)

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis.
by: Weinshenker, BG, et al.
Published: (1992)

The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome.
by: Weinshenker, BG, et al.
Published: (1991)

The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course.
by: Weinshenker, BG, et al.
Published: (1989)

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.
by: Weinshenker, BG, et al.
Published: (1989)

Systemic interferon alfa in multiple sclerosis.
by: Weinshenker, BG, et al.
Published: (1989)

The natural history of multiple sclerosis.
by: Weinshenker, BG, et al.
Published: (1987)

TIZANIDINE VERSUS BACLOFEN IN THE TREATMENT OF SPASTICITY IN PATIENTS WITH MULTIPLE-SCLEROSIS - A DOUBLE-BLIND-STUDY
by: Bass, B, et al.
Published: (1987)

Remission in psoriatic arthritis—where are we now?
by: Coates, L, et al.
Published: (2017)

Considerations for the definition of remission criteria in psoriatic arthritis
by: Mease, P, et al.
Published: (2017)

Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis.
by: Bass, B, et al.
Published: (1988)

The prevalence of primary Sjogren's syndrome in a multiple sclerosis population.
by: Noseworthy, J, et al.
Published: (1989)

Some clinical and pathologic observations on chronic myelopathy: a variant of multiple sclerosis.
by: Weinshenker, BG, et al.
Published: (1990)

HTLV-1 associated myelopathy in Canada.
by: Power, C, et al.
Published: (1989)

SIGNIFICANCE OF THE SINGLE BAND IN CSF PROTEIN ELECTROPHORESIS
by: Bass, B, et al.
Published: (1986)

Interpretation of single band patterns in CSF protein electrophoresis.
by: Bass, B, et al.
Published: (1988)

The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials.
by: Weinshenker, BG, et al.
Published: (1991)

THE NATURAL-HISTORY OF MULTIPLE-SCLEROSIS - A GEOGRAPHICALLY BASED STUDY
by: Weinshenker, B, et al.
Published: (1989)

FAILURE TO FIND PATIENTS WITH NERVOUS-SYSTEM MANIFESTATIONS OF PRIMARY SJOGRENS SYNDROME IN A MULTIPLE-SCLEROSIS CLINIC POPULATION
by: Noseworthy, J, et al.
Published: (1988)

Sustained very low disease activity and remission in psoriatic arthritis patients
by: Lubrano, E, et al.
Published: (2019)

A practical approach to the diagnosis of spinal cord lesions
by: Mariano, R, et al.
Published: (2018)

The effect of therapy on TRM in psoriatic lesions
by: Agnieszka Owczarczyk-Saczonek, et al.
Published: (2022-02-01)

SJOGRENS-SYNDROME MIMICKING MULTIPLE-SCLEROSIS - REPLY
by: Noseworthy, J, et al.
Published: (1990)

Remission of psoriasis and psoriatic arthritis during bevacizumab therapy for renal cell cancer: Erratum
Published: (2015-01-01)

FAM3C/ILEI protein is elevated in psoriatic lesions and triggers psoriasiform hyperproliferation in mice
by: Barizah Malik, et al.
Published: (2023-07-01)

The influence of pregnancy on disability from multiple sclerosis: a population-based study in Middlesex County, Ontario.
by: Weinshenker, BG, et al.
Published: (1989)

A comparison of sporadic and familial multiple sclerosis.
by: Weinshenker, BG, et al.
Published: (1990)

The effect of adalimumab on the vasculature in psoriatic skin lesions
by: S. C. A. Hanssen, et al.
Published: (2019-04-01)

Characterization of the dermoscopic features of common psoriatic lesions
by: Jun-jie LI, et al.
Published: (2019-02-01)

Comparison of different remission and low disease definitions in patients with psoriatic arthritis and evaluation of their prognostic value
by: Coates, LC, et al.
Published: (2018)

The mRNA Expression Profile of Psoriatic Lesion Distinct from Non-Lesion
by: Li X, et al.
Published: (2022-09-01)

Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
by: Coates, L, et al.
Published: (2018)

The duration of remission and minimal disease activity after initiation and discontinuation of biological agents in patients with early psoriatic arthritis (data from the all-russian psoriatic arthritis registry)
by: E. Yu. Loginova, et al.
Published: (2019-11-01)

Use of a multidimensional RAPID3 questionnaire to assess the achievement of remission and minimal disease activity in patients with early psoriatic arthritis treated according to Treat-to-target strategy
by: E. Yu. Loginova, et al.
Published: (2019-01-01)

Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort
by: van Mens, L, et al.
Published: (2017)

Presence of bacteria in psoriatic lesions: A retrospective cohort study
by: Gitanjali Bhushan, MS, et al.
Published: (2024-03-01)

Changes in Proteome of Fibroblasts Isolated from Psoriatic Skin Lesions
by: Agnieszka Gęgotek, et al.
Published: (2020-07-01)

Cutaneous lesions in psoriatic arthritis are enriched in chemokine transcriptomic pathways
by: Hanna Johnsson, et al.
Published: (2023-05-01)

Psoriatic lesions over keloidal plaques after intralesional triamcinolone
by: Jyoti Yadav, et al.
Published: (2022-01-01)